Septerna, Inc. (SEPN)
28.32
+3.58
(+14.44%)
USD |
NASDAQ |
May 14, 16:00
28.33
0.00 (0.00%)
After-Hours: 20:00
Septerna EPS Diluted (Quarterly) : -0.193 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
| Oramed Pharmaceuticals, Inc. | 0.2274 |
| Axsome Therapeutics, Inc. | -1.261 |
| Bristol Myers Squibb Co. | 1.308 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.637M |
| Revenue (Quarterly) | 26.52M |
| Total Expenses (Quarterly) | 35.16M |
| Enterprise Value | 791.31M |
| Gross Profit Margin (Quarterly) | 98.41% |
| Profit Margin (Quarterly) | -32.56% |
| Earnings Yield | -2.88% |
| Normalized Earnings Yield | -2.884 |